Literature DB >> 33819897

Synovial sarcoma with overwhelming glandular (adenocarcinoma-like) component: A case report and review of the literature.

Lukas Streich1, Daniel N Johnson2, Borislav A Alexiev2.   

Abstract

Synovial sarcoma is an uncommon tumor of soft tissue, characterized by a specific SS18-SSX1/2/4 fusion gene. It is generally a lesion composed of monomorphic spindle cells, and can sometimes show variable epithelial differentiation. Here, we present the case of a young woman with a synovial sarcoma of the abdominal wall that showed an overwhelming (>90 %) epithelial glandular component mimicking adenocarcinoma, and only rare spindled areas. The diagnosis was confirmed by detection of targeted fusion transcripts associated with synovial sarcoma. We review the literature pertaining to synovial sarcoma, and we show that this case is only the sixth molecularly proven epithelial predominant synovial sarcoma in the literature. This report emphasizes the importance of molecular approaches in modern soft tissue pathology. Recognition of synovial sarcoma with predominant glandular component is imperative in order to avoid misdiagnosis of the tumor as metastatic adenocarcinoma, another type of sarcoma with epithelial differentiation, or a carcinoma with a sarcomatous component (sarcomatoid carcinoma), all of which have markedly different clinical management.
Copyright © 2021. Published by Elsevier GmbH.

Entities:  

Keywords:  Overwhelming glandular; SSX-SS18 fusion; Sarcoma pathology; Soft tissue pathology; Synovial sarcoma

Mesh:

Substances:

Year:  2021        PMID: 33819897     DOI: 10.1016/j.prp.2021.153418

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  1 in total

1.  Predominantly epithelial-type synovial sarcoma with overwhelming neuroendocrine differentiation: a potential diagnostic pitfall.

Authors:  Ying Chen; Ning Zhou; Deyu Guo; Xiaodong Wang; Xin He; Yujuan Xu
Journal:  Diagn Pathol       Date:  2022-07-11       Impact factor: 3.196

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.